A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer
Background/Objectives: We evaluated the efficacy and safety of first-line treatment with a programmed death-ligand 1 (PD-L1) inhibitor plus platinum-based chemotherapy versus chemotherapy alone in patients aged ≥75 years with extensive-stage small cell lung cancer (ES-SCLC). Methods: We retrospectively analyzed the pat...